GlaxoSmithKline granted FDA approval for drug to treat multiple myeloma
August 06, 2020 at 11:19 AM EDT
GlaxoSmithKline said the treatment was granted an accelerated approval based on patient response rate in clinical trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|